Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T

Purpose. To noninvasively assess liver fibrosis using combined-contrast-enhanced (CCE) magnetic resonance imaging (MRI) and texture analysis. Materials and Methods. In this IRB-approved, HIPAA-compliant prospective study, 46 adults with newly diagnosed HCV infection and recent liver biopsy underwent CCE liver MRI following intravenous administration of superparamagnetic iron oxides (ferumoxides) and gadolinium DTPA (gadopentetate dimeglumine). The image texture of the liver was quantified in regions-of-interest by calculating 165 texture features. Liver biopsy specimens were stained with Masson trichrome and assessed qualitatively (METAVIR fibrosis score) and quantitatively (% collagen stained area). Using L 1 regularization path algorithm, two texture-based multivariate linear models were constructed, one for quantitative and the other for quantitative histology prediction. The prediction performance of each model was assessed using receiver operating characteristics (ROC) and correlation analyses. Results. The texture-based predicted fibrosis score significantly correlated with qualitative (r = 0.698, P < 0.001) and quantitative (r = 0.757, P < 0.001) histology. The prediction model for qualitative histology had 0.814–0.976 areas under the curve (AUC), 0.659–1.000 sensitivity, 0.778–0.930 specificity, and 0.674–0.935 accuracy, depending on the binary classification threshold. The prediction model for quantitative histology had 0.742–0.950 AUC, 0.688–1.000 sensitivity, 0.679–0.857 specificity, and 0.696–0.848 accuracy, depending on the binary classification threshold. Conclusion. CCE MRI and texture analysis may permit noninvasive assessment of liver fibrosis.

[1]  H. Fujita,et al.  Computer-aided diagnosis of hepatic fibrosis: preliminary evaluation of MRI texture analysis using the finite difference method and an artificial neural network. , 2007, AJR. American journal of roentgenology.

[2]  Claude B Sirlin,et al.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. , 2006, Radiology.

[3]  Shi-Nine Yang,et al.  Extracting periodicity of a regular texture based on autocorrelation functions , 1997, Pattern Recognit. Lett..

[4]  H. Akaike A new look at the statistical model identification , 1974 .

[5]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .

[6]  W. Marsden I and J , 2012 .

[7]  S. Aime,et al.  Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition , 2009, Journal of magnetic resonance imaging : JMRI.

[8]  Mee Young Park,et al.  L1‐regularization path algorithm for generalized linear models , 2007 .

[9]  H. Saito,et al.  Efficacy of non-invasive elastometry on staging of hepatic fibrosis. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  T. Matsumoto,et al.  Hepatic parenchymal enhancement in the cirrhotic liver: evaluation by triple-phase dynamic MRI , 2001, Abdominal Imaging.

[11]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[12]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[13]  Isamu Ohashi,et al.  Apparent diffusion coefficient measurements with diffusion‐weighted magnetic resonance imaging for evaluation of hepatic fibrosis , 2005, Journal of magnetic resonance imaging : JMRI.

[14]  C. Aubé,et al.  Diagnostic et quantification de la fibrose hépatique par IRM de diffusion : résultats préliminaires , 2004 .

[15]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[16]  Mee Young Park,et al.  L 1-regularization path algorithm for generalized linear models , 2006 .

[17]  Georges Voronoi Nouvelles applications des paramètres continus à la théorie des formes quadratiques. Deuxième mémoire. Recherches sur les parallélloèdres primitifs. , 1908 .

[18]  R. Standish,et al.  Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient , 2009, Hepatology.

[19]  U. Motosugi,et al.  Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[20]  S. L. Murphy,et al.  Deaths: final data for 2002. , 2004, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[21]  Anil K. Jain,et al.  Texture Analysis , 2018, Handbook of Image Processing and Computer Vision.

[22]  J. Rockstroh,et al.  Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes? , 2010, Current opinion in HIV and AIDS.

[23]  P. Marcellin Hepatitis B and hepatitis C in 2009 , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[24]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .

[25]  Daniele Marin,et al.  Emerging applications for ferumoxytol as a contrast agent in MRI , 2015, Journal of magnetic resonance imaging : JMRI.

[26]  R. Ehman,et al.  Magnetic resonance elastography of liver. , 2014, Magnetic resonance imaging clinics of North America.

[27]  N. Afdhal,et al.  Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.

[28]  A. Manduca,et al.  Assessment of hepatic fibrosis with magnetic resonance elastography. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  A. Burroughs,et al.  Assessment of fibrosis and cirrhosis in liver biopsies: an update. , 2011, Seminars in liver disease.

[30]  W. Kim,et al.  The global impact of hepatic fibrosis and end-stage liver disease. , 2008, Clinics in liver disease.

[31]  Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. , 1994, Hepatology.

[32]  D. Thabut,et al.  A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease , 2002, Comparative hepatology.

[33]  S. Kakar,et al.  Contributions to Hepatic Fibrosis in HIV-HCV Coinfected and HCV Monoinfected Patients , 2006, The American Journal of Gastroenterology.

[34]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[35]  R. Weissleder,et al.  Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. , 1990, Radiology.

[36]  Superparamagnetic iron oxide: clinical time-response study. , 1991, European journal of radiology.

[37]  A. Gamst,et al.  Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast‐enhanced magnetic resonance images , 2012, Journal of magnetic resonance imaging : JMRI.

[38]  A. Gabriel,et al.  The Comparison of Scoring Scales for Liver Biopsy Assessment in Morbidly Obese Patients Undergoing Bariatric Surgery , 2005, Obesity surgery.

[39]  A. Gamst,et al.  Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis , 2007, Journal of magnetic resonance imaging : JMRI.

[40]  B. Bell,et al.  Chronic liver disease mortality in the United States, 1990–1998 , 2004, Hepatology.

[41]  C. Aubé,et al.  [Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results]. , 2004, Journal de radiologie.

[42]  Sang Joon Kim,et al.  A Mathematical Theory of Communication , 2006 .

[43]  M. O'brien,et al.  An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. , 2000, American journal of clinical pathology.

[44]  R. Fisher,et al.  Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  S. Saini,et al.  Liver-specific MR imaging contrast agents. , 1998, Radiologic clinics of North America.

[46]  B. V. Van Beers,et al.  Liver fibrosis: non‐invasive assessment with MR elastography , 2006, NMR in biomedicine.

[47]  Enrico Rossi,et al.  Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. , 2003, Clinical chemistry.

[48]  P. Deb Finite Mixture Models , 2008 .

[49]  R. Malekzadeh,et al.  Reversibility of cirrhosis in chronic hepatitis B. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[50]  H. Wilson,et al.  Computation of geometrical and inertial properties for general areas and volumes of revolution , 1976 .

[51]  Richard L Ehman,et al.  MR elastography of the liver: preliminary results. , 2006, Radiology.

[52]  J. Hoefs,et al.  Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. , 2011, Gastroenterology.

[53]  Neil Kaplowitz,et al.  Liver biology and pathobiology , 2006, Hepatology.

[54]  Richard L Ehman,et al.  Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications , 2007, Hepatology.

[55]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[56]  M. Tzalonikou,et al.  Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging , 2001, Abdominal Imaging.

[57]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[58]  P. Thampanitchawong,et al.  Liver biopsy:complications and risk factors. , 1999, World journal of gastroenterology.